Jeffrey J. Olson

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

W.K. Alfred Yung, Robert E. Albright, Jeffrey J. Olson et al. · British Journal of Cancer · 2000 · 932 citations · Full text

Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines

Kyle Ellrott, Matthew H. Bailey, Gordon Saksena et al. · Cell Systems · 2018 · 895 citations · Full text

Engineering, Genetics, Genomics +17

Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

W.K. Alfred Yung, Michael D. Prados, Ricardo Yayá et al. · Journal of Clinical Oncology · 1999 · 757 citations

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

Eric M. Thompson, Thomas Hielscher, Éric Bouffet et al. · The Lancet Oncology · 2016 · 356 citations · Full text

Neuro-oncology, Surgical Oncology, Medulloblastoma Extent +7

Divergent clonal selection dominates medulloblastoma at recurrence

A. Sorana Morrissy, Livia Garzia, David Shih et al. · Nature · 2016 · 339 citations · Full text

Neuro-oncology, Somatic Variant, Tumor Heterogeneity +5